Several Methods for Early Diagnosis of Alzheimer’s Disease Developed

ScienceDaily (June 15, 2011) — PredictAD is an EU-funded research project that develops objective and efficient methods for enabling earlier diagnosis of Alzheimer’s disease. Diagnosis requires a holistic view of the patient combining information from several sources, such as, clinical tests, imaging and blood samples.

“The aim of the PredictAD project is to develop an objective indicator to diagnose Alzheimer’s disease at the earliest stage possible. Current diagnostic guidelines emphasise the importance of various biomarkers in diagnostics. We have developed novel approaches to extract biomarkers from imaging data, electrophysiological data and blood samples, and a unique and clinically useful software tool for integrating all these heterogeneous measurements.” says the Scientific Coordinator of the project, Dr Jyrki Lötjönen from VTT Technical Research Centre of Finland.

Magnetic resonance imaging for identifying atrophy

 

Atrophy in the mediotemporal lobe is a well-known hallmark of Alzheimer’s disease. Magnetic resonance imaging is an excellent tool for measuring this tissue loss. In current clinical practice, images are interpreted mostly only by visual inspection but there is a great need for objective measurements.

PredictAD has developed several methods to meet this need. “We have managed to develop efficient tools for measuring the size of the hippocampus, the atrophy rate of the hippocampus, and two modern approaches based on comparing patient data with previously diagnosed cases available in large databases.” says the leader of the imaging biomarkers work-package, professor Daniel Rueckert from Imperial College London. Positron emission tomography (PET) imaging is another imaging technology studied in the project. A novel tracer developed recently especially for diagnostics of Alzheimer’s disease provides promises for very early diagnosis of the disease.

Detecting changes in the electrophysiology of the brain

 

Alzheimer’s disease is known to affect the electromagnetic activity of the brain. In PredictAD, we have studied the performance of a novel technology, transcranial magnetic stimulation (TMS) combined with electroencephalographic (EEG) measures in detecting the disease. The strength of TMS/EEG is that it allows direct and non-invasive perturbation of the human cerebral cortex without requiring the subject’s collaboration. Our study has shown significant changes in Alzheimer’s patients compared with healthy aging people.

Non-invasive techniques to find biomarkers of the disease

 

Molecular level biomarkers are currently under extensive studies in Alzheimer’s research. Many biomarkers, such as tau proteins and b-amyloid 42, measured from the cerebrospinal fluid (CSF), the liquid surrounding the cerebral cortex, have been found to be strongly related with the disease. One major challenge of these biomarkers is that taking samples from CSF is an invasive measurement limiting their usability in early diagnostics. Blood samples would be an excellent source for detecting Alzheimer’s disease as blood sampling is not considered an invasive technique. PredictAD has studied the role of metabolomic and protein compounds in Alzheimer’s disease from blood samples. The preliminary results reveal several promising compounds.

Methodology for measuring the state of the patient

 

Currently, clinicians make the final diagnosis by combining heterogeneous measurements with information from interviews of the patient and relatives. This process involves subjective reasoning and requires strong expertise from the clinicians. Modern hospitals have huge data reserves containing hidden information that could be utilised in diagnostics by systematic mathematical modelling.

PredictAD has designed a totally novel approach for measuring objectively the state of the patient. This decision support system, developed in close collaboration with clinicians, compares patient measurements with measurements of other patients in large databases and provides at the end an index and graphical representation reflecting the state of the patient. “The PredictAD tool provides a new option to support decision making,” says Prof. Hilkka Soininen from the University of Eastern Finland, leading the clinical validation of the project.

Possibilities for significant savings in health costs

 

Prof. Gunhild Waldemar from Copenhagen University Hospital, Rigshospitalet emphasises the importance of the Alzheimer’s disease research: “Successful, early diagnostics combined with the novel drugs under development and early psychosocial care may delay the institutionalisation of patients, reducing suffering and the costs to the society. It has been calculated that delaying the onset of the disease by five years would halve all costs of Alzheimer’s disease and delaying onset and progression by only one year would reduce the number of Alzheimer’s cases by about 10%.”

Read more http://www.sciencedaily.com/releases/2011/06/110615062000.htm

Share

Posted: June 16th, 2011 under Uncategorized.

RSS Medical Imaging News

  • MRI pinpoints region of brain injury in some concussion patients April 15, 2014
    Researchers using information provided by a magnetic resonance imaging technique have identified regional white matter damage in the brains of people who experience chronic dizziness and other symptoms after concussion. The findings suggest that information provided by MRI can speed the onset of effective treatments for concussion patients.
  • New PET/CT scanner more patient friendly April 10, 2014
    A new patient-friendly PET/CT scanner does combined exams in just 15 or 20 minutes, and the patient is never completely enclosed. The state-of-the-art system is improving the diagnosis and treatment of cancer, heart disease, epilepsy, Alzheimer's disease and other conditions. "It is the most patient-friendly system of its kind," said a hospita […]
  • Potential marker to better identify, resect glioblastoma multiforme tumors April 7, 2014
    Researchers have highlighted the results of research that explores whether 5 aminolevulinic-acid fluorescence (5-ALA) offers additional detection benefits compared to intraoperative MRI (iMRI) when dealing with invasive tumors.
  • Green tea extract boosts your brain power, especially the working memory, new research shows April 7, 2014
    Green tea is said to have many putative positive effects on health. Now, researchers are reporting first evidence that green tea extract enhances the cognitive functions, in particular the working memory. The findings suggest promising clinical implications for the treatment of cognitive impairments in psychiatric disorders such as dementia.
  • New method for prostate cancer detection can save millions of men painful examination April 7, 2014
    Each year prostate tissue samples are taken from over a million men around the world -- in most cases using 12 large biopsy needles -- to check whether they have prostate cancer. This medical procedure shows that 70% of the subjects do not have cancer. The examination is unnecessarily painful and involves risk for these patients, and it is also costly to car […]
  • Role of magnetic nanoparticles in breast cancer treatment April 7, 2014
    While exploring the promise of magnetic nanoparticle (mNP) hyperthermia in breast cancer treatment, a researcher reviews preclinical studies and discusses plans for early-phase clinical studies in humans. This evolving treatment approach involves the injection of nanoparticles into the tumor, which are then activated with magnetic energy. Once activated the […]
  • Six months hormonal treatment in addition to radiotherapy improves survival for men with localized prostate cancer April 7, 2014
    Men with prostate cancer that is small and confined to the prostate gland but that is at risk of growing and spreading, do better if they are treated with radiotherapy combined with androgen deprivation therapy, which lowers their levels of the male hormone, testosterone, according to new research.
  • Non-invasive imaging instead of repeated biopsy in active monitoring of prostate cancer April 6, 2014
    A novel method to 'manipulate the lipid metabolism in the cancer cell to trick them to use more radiolabeled glucose, the basis of PET scanning' is being described by researchers. The current study used the clinically safe drug etomoxir to block prostate cancer cells' ability to oxidize lipids. With the lipid energy source removed, cells switc […]
  • Toward a clearer diagnosis of chronic fatigue syndrome April 4, 2014
    Functional PET imaging to show that levels of neuroinflammation, or inflammation of the nervous system, are higher in patients with chronic fatigue syndrome than in healthy people, research has shown. Chronic fatigue syndrome, which is also known as myalgic encephalomyelitis, is a debilitating condition characterized by chronic, profound, and disabling fatig […]
  • Diffeomorphometry, geodesic positioning systems for human anatomy April 3, 2014
    New algorithmic technologies for the parametric representation of human shape and form have been recently demonstrated by researchers. Coupled with advanced imaging technologies, this presents opportunities for tracking soft-tissue deformations associated with cardiovascular studies, radiation treatment planning in oncology, and neurodegenerative brain illne […]

News Items

Links